RBPJ and Cholestatic liver disease: In contrast to the in vitro model, the in vivo mouse model depicted a cholestatic liver disease only in Rbpj−/− mice due to impaired IHBD maturation, Rbpj+/+ mice did not develop a cholestatic liver disease.